AIA “virtual biotech” reportedly analyzed 57,000 clinical trials using 37,000 AI agents
Biohub says investigator James Zou built the system, which found clues to what makes drugs succeed.
TLDR
Biohub says James Zou’s “virtual biotech” used 37,000 AI agents to analyze 57,000 clinical trials and find clues to drug success. The organization says The New York Times traces the project’s roots to a collaboration sparked by Biohub scientist John Pak.
A “virtual biotech” reportedly analyzed 57,000 clinical trials using 37,000 AI agents
Biohub says investigator James Zou built the system, which found clues to what makes drugs succeed.
TLDR
Biohub says James Zou’s “virtual biotech” used 37,000 AI agents to analyze 57,000 clinical trials and find clues to drug success. The organization says The New York Times traces the project’s roots to a collaboration sparked by Biohub scientist John Pak.
